ELUFREZ
LIVE

Serial Number

79255628

Owner

Glaxo Group Limited

Attorney

Merilee J. Arevalo

Filing Date

Mar 7, 2019

Add to watchlist:

No watchlists yet
View on USPTO

ELUFREZ Trademark

Serial Number: 79255628 • Registration: 5905903

ELUFREZ is a trademark filed by Glaxo Group Limited on March 7, 2019. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently registered and active.

Owner Contact Info

Glaxo Group Limited (128 trademarks)

GSK Medicines Research Centre
Stevenage SG12NY , GB

Entity Type: 77

Trademark Details

Filing Date

March 7, 2019

Registration Date

November 12, 2019

Published for Opposition

August 27, 2019

Cancellation Date

May 29, 2026

Goods & Services

Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; vaccines

Filing History

CANCELLED SECTION 71
May 29, 2026 C71T
NEW REPRESENTATIVE AT IB RECEIVED
Jun 5, 2025 NREP
COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
Nov 12, 2024 REM3
INTERNATIONAL REGISTRATION RENEWED
May 2, 2024 RNWL
CHANGE OF NAME/ADDRESS REC'D FROM IB
Jul 23, 2023 ADCH
FINAL DECISION TRANSACTION PROCESSED BY IB
Apr 24, 2020 FINO
FINAL DISPOSITION NOTICE SENT TO IB
Mar 6, 2020 FICS
FINAL DISPOSITION PROCESSED
Mar 6, 2020 FIMP
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Feb 12, 2020 FICR
REGISTERED-PRINCIPAL REGISTER
Nov 12, 2019 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Aug 27, 2019 NPUB
PUBLISHED FOR OPPOSITION
Aug 27, 2019 PUBO
NOTIFICATION PROCESSED BY IB
Aug 23, 2019 GPNX
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Aug 7, 2019 OPNS
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Aug 7, 2019 OP2R
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Aug 7, 2019 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Jul 23, 2019 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Jul 18, 2019 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jul 18, 2019 CRFA
ASSIGNED TO LIE
Jul 18, 2019 ALIE
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jul 12, 2019 TROA
REFUSAL PROCESSED BY IB
May 17, 2019 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Apr 29, 2019 RFCS
REFUSAL PROCESSED BY MPU
Apr 29, 2019 RFRR
APPLICATION FILING RECEIPT MAILED
Apr 9, 2019 MAFR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Apr 6, 2019 RFCR
NON-FINAL ACTION WRITTEN
Apr 5, 2019 CNRT
ASSIGNED TO EXAMINER
Apr 3, 2019 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Apr 3, 2019 NWOS
SN ASSIGNED FOR SECT 66A SUBSEQ DESIG FROM IB
Mar 28, 2019 SDRC